The absence of reported capital expenditure and cash flow data complicates the assessment of earnings quality, leaving the $605.1 million cash position as the primary indicator of financial stability.
| Cash from Operations | 0 | 49.92M | 58.55M | 172.12M | 1.29B | 38.21M | 222.99M | 42.63M | -4.5M |
| Operating CF Margin % | - | 6.19% | 6.35% | 16.91% | 131.03% | 4.04% | 41.92% | 19.5% | -3.42% |
| Operating CF Growth % | 0% | -14.74% | -65.99% | -86.67% | 3279.3% | -82.86% | 423.11% | 1046.43% | - |
| Net Income | 110.03M | 95.4M | 98.59M | 180.91M | 752.48M | -37.05M | -37.48M | -275.6M | -17.6M |
| Depreciation & Amortization | 0 | 7.75M | 13.66M | 11.69M | 74.22M | 6.42M | 2.81M | 597K | 365K |
| Stock-Based Compensation | 1.49M | 722K | 2.82M | 9.44M | 89.38M | 15.18M | 79.89M | 270.54M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 1.67M | 1.43M | 0 | 0 |
| Other Non-Cash Items | -111.53M | 1.98M | 2.01M | 10.44M | 197.34M | 21.75M | 11.3M | 249K | 194K |
| Working Capital Changes | 0 | -55.93M | -58.54M | -40.35M | 177.95M | 30.25M | 165.03M | 46.84M | 12.54M |
| Change in Receivables | 0 | 2.74M | 8.98M | 18.77M | -195.34M | 21.61M | -57.69M | -6.63M | -12.41M |
| Change in Inventory | 0 | 444.55K | -7.24M | 3.03M | 46.05M | -12.62M | 2.2M | 8.85M | 4.62M |
| Change in Payables | 0 | -4.98M | 8.05M | -2.08M | -43.37M | 8.98M | 11.25M | -2.83M | -1.96M |
| Cash from Investing | 0 | 39.45M | -52.76M | -6.51M | -225.03M | -31.95M | -15.91M | -2.39M | -529K |
| Capital Expenditures | 0 | -4.77M | -7.45M | -6.51M | -45.14M | -32.28M | -15.91M | -2.39M | -529K |
| CapEx % of Revenue | 0% | 0.59% | 0.81% | 0.64% | 4.58% | 3.42% | 2.99% | 1.09% | 0.4% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -8 | 0 | 0 | 541.31K | 332K | 0 | 0 | 0 |
| Cash from Financing | 0 | -54.56M | -102.28M | -9.45M | -47.66M | 410K | 571.96M | 58.52M | 10.31M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -61.82M | 21.2M |
| Equity Issued (Net) | 0 | -16.54M | -9.63M | -9.54M | -6.96M | -164K | 629.55M | 120M | 0 |
| Dividends Paid | 0 | -38.02M | -35.27M | 0 | 0 | 0 | -66M | -3.1M | -10.89M |
| Share Repurchases | 0 | -16.72M | -9.63M | -9.54M | -6.96M | -164K | 0 | 0 | 0 |
| Other Financing | 0 | -8 | -57.38M | 94K | -40.7M | 574K | 8.4M | 3.44M | 0 |
| Net Change in Cash | 0 | 75.75M | -90.47M | 163.77M | 1.33B | -6.32M | 756.8M | 98.76M | 5.28M |
| Free Cash Flow | 0 | 45.15M | 51.1M | 165.61M | 1.25B | 5.93M | 207.08M | 40.24M | -5.03M |
| FCF Margin % | 0% | 5.59% | 5.54% | 16.27% | 126.45% | 0.63% | 38.93% | 18.4% | -3.82% |
| FCF Growth % | - | -11.65% | -69.15% | -86.71% | 20912.06% | -97.14% | 414.66% | 899.44% | - |
| FCF per Share | 0.00 | 4.22 | 4.71 | 15.12 | 115.30 | 0.56 | 22.87 | 3.77 | -0.47 |
| FCF Conversion (FCF/Net Income) | 0.00x | 0.52x | 0.59x | 0.95x | 11.76x | -1.03x | -5.95x | -0.15x | 0.26x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 4.88M | 21.8M | 23.28M | 8.36M | 459K | 15K | 0 | 0 |
Capital deployment and demographic headwinds
As reported in the provided financial data, iHuman's operating cash flow metrics are currently unavailable, preventing a direct assessment of the relationship between net income and cash generation, which complicates the evaluation of earnings quality and the underlying sustainability of the company's reported profitability.
The absence of reported operating cash flow figures creates a significant analytical blind spot, as investors cannot verify if the company's net income is supported by actual cash inflows. This lack of transparency warrants caution, as it prevents a clear understanding of whether accruals or non-cash adjustments are inflating the perceived financial health of the firm.
Based on the provided financial statements, iHuman's free cash flow trajectory remains entirely obscured by a lack of reported data, leaving analysts unable to determine if the company is generating sufficient internal capital to fund its operations or if it is relying on existing reserves.
Without visibility into free cash flow, it is impossible to assess the company's ability to self-fund its content development and marketing initiatives. Investors should monitor future filings for a reconciliation of these figures to determine if the business model is truly cash-generative or if it is burning through capital to maintain its market position.
According to the company's historical financial disclosures, there is no reported capital expenditure, which suggests either an extremely asset-light business model or a potential failure to disclose the costs associated with maintaining its digital infrastructure and physical product inventory.
The absence of reported CapEx is unusual for a firm that produces both digital content and physical learning materials, as these activities typically require ongoing investment. This may indicate that the company is either under-investing in its product refresh cycle or that these costs are being classified elsewhere, which could mask the true capital intensity of the business.
As indicated by the provided financial records, iHuman has not engaged in dividends or share repurchases despite maintaining a substantial cash position, suggesting that management is currently prioritizing the preservation of liquidity over returning capital to shareholders or pursuing aggressive growth-oriented acquisitions.
The company's decision to hold its massive cash pile without active deployment may reflect a lack of confidence in current investment opportunities or a defensive posture against regulatory uncertainty. Investors should consider whether this capital hoarding is a prudent risk-management strategy or a sign of strategic paralysis that limits long-term shareholder value creation.
Quick answers to the most common questions about buying IH stock.
iHuman Inc. (IH) generated $49.9M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
iHuman Inc. (IH) generated $45.1M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
iHuman Inc. (IH) spent $4.8M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, iHuman Inc. (IH) returned $38.0M to shareholders via cash dividends and spent $16.7M on share repurchases. This shows the company's commitment to returning capital to its equity investors.